| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1Division of Nephrology, Department of Medicine, Duke University and Durham Veterans Affairs Medical Centers, Durham, North Carolina; and 2Division of Nephrology, Department of Medicine, Stanford University, Palo Alto, California
Submitted 17 May 2005 ; accepted in final form 9 August 2005
With the goal of identifying optimal platforms for developing better models of diabetic nephropathy in mice, we compared renal effects of streptozotocin (STZ)-induced diabetes among five common inbred mouse strains (C57BL/6, MRL/Mp, BALB/c, DBA/2, and 129/SvEv). We also evaluated the renal consequences of chemical and genetic diabetes on the same genetic background (C57BL/6). There was a hierarchical response of blood glucose level to the STZ regimen among the strains (DBA/2 > C57BL/6 > MRL/MP > 129/SvEv > BALB/c). In all five strains, males demonstrated much more robust hyperglycemia with STZ than females. STZ-induced diabetes was associated with modest levels of albuminuria in all of the strains but was greatest in the DBA/2 strain, which also had the most marked hyperglycemia. Renal structural changes on light microscopy were limited to the development of mesangial expansion, and, while there were some apparent differences among strains in susceptibility to renal pathological changes, there was a significant positive correlation between blood glucose and the degree of mesangial expansion, suggesting that most of the variability in renal pathological abnormalities was because of differences in hyperglycemia. Although the general character of renal involvement was similar between chemical and genetic diabetes, Akita mice developed more marked hyperglycemia, elevated blood pressures, and less variability in renal structural responses. Thus, among the strains and models tested, the DBA/2 genetic background and the Akita (Ins2+/C96Y) model may be the most useful platforms for model development.
mouse models of type I diabetes; streptozotocin; Akita mice; albuminuria; strain comparison
This article has been cited by other articles:
|
|
 |
|
  S. A. Roxburgh, J. J. Kattla, S. P. Curran, Y. M. O'Meara, C. A. Pollock, R. Goldschmeding, C. Godson, F. Martin, and D. P. Brazil Allelic Depletion of grem1 Attenuates Diabetic Kidney Disease Diabetes, July 1, 2009; 58(7): 1641 - 1650. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. C. Berthier, H. Zhang, M. Schin, A. Henger, R. G. Nelson, B. Yee, A. Boucherot, M. A. Neusser, C. D. Cohen, C. Carter-Su, et al. Enhanced Expression of Janus Kinase-Signal Transducer and Activator of Transcription Pathway Members in Human Diabetic Nephropathy Diabetes, February 1, 2009; 58(2): 469 - 477. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Athirakul, J. A. Bradbury, J. P. Graves, L. M. DeGraff, J. Ma, Y. Zhao, J. F. Couse, R. Quigley, D. R. Harder, X. Zhao, et al. Increased blood pressure in mice lacking cytochrome P450 2J5 FASEB J, December 1, 2008; 22(12): 4096 - 4108. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Bugger, S. Boudina, X. X. Hu, J. Tuinei, V. G. Zaha, H. A. Theobald, U. J. Yun, A. P. McQueen, B. Wayment, S. E. Litwin, et al. Type 1 Diabetic Akita Mouse Hearts Are Insulin Sensitive but Manifest Structurally Abnormal Mitochondria That Remain Coupled Despite Increased Uncoupling Protein 3 Diabetes, November 1, 2008; 57(11): 2924 - 2932. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. G. Han, C.-M. Hao, E. E. Tchekneva, Y.-Y. Wang, C. A. Lee, B. Ebrahim, R. C. Harris, T. S. Kern, D. H. Wasserman, M. D. Breyer, et al. Markers of glycemic control in the mouse: comparisons of 6-h- and overnight-fasted blood glucoses to Hb A1c Am J Physiol Endocrinol Metab, October 1, 2008; 295(4): E981 - E986. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Zhang, J. Saha, J. Byun, M. Schin, M. Lorenz, R. T. Kennedy, M. Kretzler, E. L. Feldman, S. Pennathur, and F. C. Brosius III Rosiglitazone reduces renal and plasma markers of oxidative injury and reverses urinary metabolite abnormalities in the amelioration of diabetic nephropathy Am J Physiol Renal Physiol, October 1, 2008; 295(4): F1071 - F1081. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Faulhaber-Walter, L. Chen, M. Oppermann, S. M. Kim, Y. Huang, N. Hiramatsu, D. Mizel, H. Kajiyama, P. Zerfas, J. P. Briggs, et al. Lack of A1 Adenosine Receptors Augments Diabetic Hyperfiltration and Glomerular Injury J. Am. Soc. Nephrol., April 1, 2008; 19(4): 722 - 730. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E.-G. Hong, D. Y. Jung, H. J. Ko, Z. Zhang, Z. Ma, J. Y. Jun, J. H. Kim, A. D. Sumner, T. C. Vary, T. W. Gardner, et al. Nonobese, insulin-deficient Ins2Akita mice develop type 2 diabetes phenotypes including insulin resistance and cardiac remodeling Am J Physiol Endocrinol Metab, December 1, 2007; 293(6): E1687 - E1696. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Chalothorn, J. A. Clayton, H. Zhang, D. Pomp, and J. E. Faber Collateral density, remodeling, and VEGF-A expression differ widely between mouse strains Physiol Genomics, July 18, 2007; 30(2): 179 - 191. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Keck, M. J. Romero-Aleshire, Q. Cai, P. B. Hoyer, and H. L. Brooks Hormonal status affects the progression of STZ-induced diabetes and diabetic renal damage in the VCD mouse model of menopause Am J Physiol Renal Physiol, July 1, 2007; 293(1): F193 - F199. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Hsueh, E. D. Abel, J. L. Breslow, N. Maeda, R. C. Davis, E. A. Fisher, H. Dansky, D. A. McClain, R. McIndoe, M. K. Wassef, et al. Recipes for Creating Animal Models of Diabetic Cardiovascular Disease Circ. Res., May 25, 2007; 100(10): 1415 - 1427. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. B. Wichi, V. Farah, Y. Chen, M. C. Irigoyen, and M. Morris Deficiency in angiotensin AT1a receptors prevents diabetes-induced hypertension Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2007; 292(3): R1184 - R1189. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. E. Tchekneva, E. M. Rinchik, D. Polosukhina, L. S. Davis, V. Kadkina, Y. Mohamed, S. R. Dunn, K. Sharma, Z. Qi, A. B. Fogo, et al. A Sensitized Screen of N-ethyl-N-nitrosourea-Mutagenized Mice Identifies Dominant Mutants Predisposed to Diabetic Nephropathy J. Am. Soc. Nephrol., January 1, 2007; 18(1): 103 - 112. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Nasrallah, H. Xiong, and R. L. Hebert Renal prostaglandin E2 receptor (EP) expression profile is altered in streptozotocin and B6-Ins2Akita type I diabetic mice Am J Physiol Renal Physiol, January 1, 2007; 292(1): F278 - F284. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Kanetsuna, K. Hirano, M. Nagata, M. A. Gannon, K. Takahashi, R. C. Harris, M. D. Breyer, and T. Takahashi Characterization of diabetic nephropathy in a transgenic model of hypoinsulinemic diabetes Am J Physiol Renal Physiol, December 1, 2006; 291(6): F1315 - F1322. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Ye, J. Wysocki, J. William, M. J. Soler, I. Cokic, and D. Batlle Glomerular Localization and Expression of Angiotensin-Converting Enzyme 2 and Angiotensin-Converting Enzyme: Implications for Albuminuria in Diabetes J. Am. Soc. Nephrol., November 1, 2006; 17(11): 3067 - 3075. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Vignali, V. Leiss, R. Karl, F. Hofmann, and A. Welling Characterization of voltage-dependent sodium and calcium channels in mouse pancreatic A- and B-cells J. Physiol., May 1, 2006; 572(3): 691 - 706. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
